Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics reported Q2 revenue of $36.9M (down 36% YoY) and billings of $65.5M (down 34% YoY), alongside a wider net loss of $14.9M (vs. $9.3M a year ago) and negative operating cash flow of $(8.6)M. The company improved advertiser churn and raised efficiency, with adjusted EBITDA at $1.7M (vs. $3.0M prior year), while liquidity remains $28M cash with $20M available on its credit facility. Management guided Q3 billings of $61M–$67M, revenue of $34M–$39M, and adjusted EBITDA of $0M–$3M, signaling stabilization but no near-term earnings inflection. AI initiatives—including an AI-driven campaign publishing engine that cuts ad build time ~50%—are positioned as a catalyst for improved campaign efficiency and deeper spend insights.

Analysis

The core issue is not the headline P&L miss; it is that the company’s economic engine is still being resized by partner renegotiations, and the new steady state looks lower than the prior base. Even with cost cuts, negative operating cash flow and shrinking user reach mean the model is still consuming liquidity faster than it is converting advertiser momentum into cash. That matters because a recovery in adjusted EBITDA is less relevant if cash burn persists and management is forced to prioritize balance-sheet preservation over growth investment.

The competitive implication is that banks now have more leverage, not less. If issuers and platforms can shift toward merchant-funded, localized offers at lower shared economics, CDLX can keep the volume but may structurally give up take-rate unless its AI tooling and personalization demonstrably raise advertiser ROI. That should help smaller merchants and bank partners seeking cheaper rewards, while pressuring legacy points-based programs and adjacent offer networks that rely on broader, less targeted inventory. The second-order risk is that improved advertiser metrics can coexist with weaker company economics if inventory quality remains constrained.

Timeline matters: over the next 1-3 months, the stock is likely to trade on liquidity and guidance credibility, not on the AI narrative. Over 6-18 months, the key question is whether new bank wins and UK expansion can offset the U.S. partner reset before the company needs dilutive capital. The contrarian setup is that the market may be over-penalizing the top-line decline while underestimating the advertiser churn improvement; but that only matters if free cash flow visibly inflects, not if the business merely stabilizes at a lower level.

Key Decisions for Investors

• Short CDLX on post-earnings strength or any rally tied to the AI/product narrative; thesis is that cash burn and lower MQUs keep multiple expansion capped until at least Q1 2027.
• Buy 3-6 month CDLX put spreads as a defined-risk way to express downside from a liquidity squeeze or another guide-down; thesis falsifies if free cash flow improves meaningfully for two consecutive quarters.
• If already long, trim into rallies and keep only a starter position until management shows revenue stabilization and operating cash flow moving toward breakeven; watch Q3 billings midpoint versus Q2 as the first test.
• Set a hard alert on cash plus revolver usage versus quarterly burn; if burn stays near the current run-rate for another quarter, expect financing overhang and reassess the short thesis as a dilution trade rather than just an earnings trade.